IXICO plc (LON:IXI – Get Free Report)’s share price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 7.86 and traded as low as GBX 7. IXICO shares last traded at GBX 7.18, with a volume of 226,084 shares changing hands.
IXICO Trading Down 4.3%
The firm has a market cap of £15.71 million, a price-to-earnings ratio of -3.68, a PEG ratio of -0.38 and a beta of 0.11. The business has a fifty day moving average of GBX 8 and a two-hundred day moving average of GBX 7.86. The company has a debt-to-equity ratio of 5.22, a quick ratio of 4.90 and a current ratio of 2.83.
Insider Activity at IXICO
In other IXICO news, insider Mark Warne acquired 50,006 shares of the stock in a transaction that occurred on Wednesday, July 15th. The shares were purchased at an average cost of GBX 8 per share, with a total value of £4,000.48. 3.07% of the stock is owned by corporate insiders.
About IXICO
IXICO is a global leader in neuroscience imaging and biomarker analytics, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring.
By unlocking valuable insights into drug safety and efficacy, IXICO has built a global reputation and 20-year track record as an end-to-end Imaging Contract Research Organisation (iCRO) managing and analysing neurological clinical trials.
Further Reading
- Five stocks we like better than IXICO
- Nasdaq’s $100 Million Kraken Bet Prepares It for a Market That Never Closes
- Copper’s Record Rally Highlights a Deeper Supply Problem
- Rocket Lab Tackles a Supply Chain Bottleneck as the Stock Hunts for a Bottom. Time to Buy?
- Optical Cable Corporation Is Starting to Get the Market’s Attention
Receive News & Ratings for IXICO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IXICO and related companies with MarketBeat.com's FREE daily email newsletter.
